A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective?
Author:
Funder
Asadabad School of Medical Science
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Immunology
Link
https://link.springer.com/content/pdf/10.1007/s10787-022-01129-1.pdf
Reference120 articles.
1. Agostini ML, Andres EL, Sims AC, Graham RL, Sheahan TP, Lu X, Jordan R (2018) Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. Mbio 9(2):e00221-e1218
2. Ahmed S, Karim MM, Ross AG, Hossain MS, Clemens JD, Sumiya MK, Somani J (2021) A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness. Int J Infect Dis 103:214–216
3. Al-Kuraishy HM, Hussien NR, Al-Naimi MS, Al-Buhadily AK, Al-Gareeb AI, Lungnier C (2020) Is ivermectin–Azithromycin combination the next step for COVID-19? Biomed Biotechnol Res J (BBRJ) 4(5):101
4. Al-Tawfiq JA, Momattin H, Dib J, Memish ZA (2014) Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int J Infect Dis 20:42–46
5. Anderson KL, Strowd LC (2017) Epidemiology, diagnosis, and treatment of scabies in a dermatology office. J Am Board Family Med 30(1):78–84
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of Ivermectin on the Gut Microbial Ecosystem;International Journal of Molecular Sciences;2023-11-09
2. Topical ivermectin ointment treatment of Demodex blepharitis: a 6-year retrospective study;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-11-01
3. Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases;Cell Communication and Signaling;2023-05-15
4. CD147 and cyclophilin A: a promising potential targeted therapy for COVID-19 and associated cancer progression and chemo-resistance;Infectious Agents and Cancer;2023-04-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3